141 related articles for article (PubMed ID: 27081721)
1. Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining Caveats.
Malik P
Mol Ther; 2016 Apr; 24(4):668-70. PubMed ID: 27081721
[No Abstract] [Full Text] [Related]
2. Taking the good out of the bad: lentiviral-based gene therapy of the hemoglobinopathies.
Stathopulos PB
Biotechnol Adv; 2003 Sep; 21(6):513-26. PubMed ID: 14499152
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for hemoglobinopathies: the state of the field and the future.
Chandrakasan S; Malik P
Hematol Oncol Clin North Am; 2014 Apr; 28(2):199-216. PubMed ID: 24589262
[TBL] [Abstract][Full Text] [Related]
4. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
Payen E; Leboulch P
Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
[TBL] [Abstract][Full Text] [Related]
5. The double life of lentiviruses.
Nat Methods; 2006 Feb; 3(2):69. PubMed ID: 16468172
[No Abstract] [Full Text] [Related]
6. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
7. Lenti in red: progress in gene therapy for human hemoglobinopathies.
von Kalle C; Baum C; Williams DA
J Clin Invest; 2004 Oct; 114(7):889-91. PubMed ID: 15467825
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy using hematopoietic stem cells.
Kohn DB
Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
[TBL] [Abstract][Full Text] [Related]
10. Viral Vectors for Gene Therapy: Translational and Clinical Outlook.
Kotterman MA; Chalberg TW; Schaffer DV
Annu Rev Biomed Eng; 2015; 17():63-89. PubMed ID: 26643018
[TBL] [Abstract][Full Text] [Related]
11. Hopes, Promises, and Future Directions of Gene and Cell Therapies in France.
Cartier N; Cordelier P
Hum Gene Ther; 2016 Feb; 27(2):96-7. PubMed ID: 26886830
[No Abstract] [Full Text] [Related]
12. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future.
Vichinsky EP
Hematol Oncol Clin North Am; 2014 Apr; 28(2):xiii-xviii. PubMed ID: 24589274
[No Abstract] [Full Text] [Related]
13. Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
Perumbeti A; Malik P
Ann N Y Acad Sci; 2010 Aug; 1202():36-44. PubMed ID: 20712770
[TBL] [Abstract][Full Text] [Related]
14. Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis.
Flotte TR; Ng P; Dylla DE; McCray PB; Wang G; Kolls JK; Hu J
Mol Ther; 2007 Feb; 15(2):229-41. PubMed ID: 17235299
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus and lentivirus pseudotypes for lung-directed gene therapy.
Wilson JM
Proc Am Thorac Soc; 2004; 1(4):309-14. PubMed ID: 16113451
[TBL] [Abstract][Full Text] [Related]
16. Non-viral gene therapy.
Treco DA; Selden RF
Mol Med Today; 1995 Oct; 1(7):314-21. PubMed ID: 9415171
[TBL] [Abstract][Full Text] [Related]
17. Trial watch: Clinical trial boost for lentiviral gene therapy.
Flight MH
Nat Rev Drug Discov; 2013 Sep; 12(9):654. PubMed ID: 23989781
[No Abstract] [Full Text] [Related]
18. RNAi therapy: dominant disease gene gets silenced.
Xu Z; Xia XG
Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
[No Abstract] [Full Text] [Related]
19. [Progress in improvement of lentiviral vectors' transcriptional read-through].
He J; Zhang J
Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1541-8. PubMed ID: 22393708
[TBL] [Abstract][Full Text] [Related]
20. Moving gene therapy forward with mobile DNA.
VandenDriessche T; Chuah MK
Hum Gene Ther; 2009 Dec; 20(12):1559-61. PubMed ID: 19919494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
